Novel stem cell therapy for acute myocardial infarction in diabetes mellitus
Ended Project Grant Awarded Last action
- Award ID
- R43HL132774
- Recipient
-
Transtarget, Inc. UEI ZK1CMJHQMGM6
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,909
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $224,909 |
Quick answers
Who received award R43HL132774?
R43HL132774 was awarded to Transtarget, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 19, 2016.
How much is award R43HL132774 worth?
$224,909 has been obligated on R43HL132774.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award